Patients’ Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice

Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice

(2018) P. Hansson et al.   EUROPEAN JOURNAL OF PAIN

Transdermal and Topical Drug Administration in the Treatment of Pain

(2018) Wojciech Leppert et al.   MOLECULES

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study

(2017) David M. Simpson et al.   JOURNAL OF PAIN

Localized neuropathic pain: an expert consensus on local treatments

(2017) Gisèle PICKERING et al.   Drug Design Development and Therapy

Neuropathic pain

(2017) Luana Colloca et al.   Nature Reviews Disease Primers

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

(2016) Patrick Vermersch et al.   Multiple Sclerosis Journal

Neuropathic pain

(2016) Nanna B. Finnerup et al.   PAIN

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

(2016) Patrick Vermersch et al.   Multiple Sclerosis Journal

A Retrospective Study of Chronic Post-Surgical Pain following Thoracic Surgery: Prevalence, Risk Factors, Incidence of Neuropathic Component, and Impact on Qualify of Life

(2014) Zhiyou Peng et al.   PLoS One

Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study

(2013) C. Maihofner et al.   CURRENT MEDICAL RESEARCH AND OPINION

Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices

(2013) Fabrizio Conti et al.   PLoS One

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

(2011) P. Anand et al.   BRITISH JOURNAL OF ANAESTHESIA

A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy

(2011) David B. Clifford et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The specific disease burden of neuropathic pain: Results of a French nationwide survey

(2011) Nadine Attal et al.   PAIN

Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome

(2010) Norman R. Harden et al.   PAIN

A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia

(2010) Gordon A. Irving et al.   PAIN MEDICINE

Pain outcomes: A brief review of instruments and techniques

(2009) Jarred Younger et al.   Current Pain and Headache Reports

Assessment of pain

(2008) H. Breivik et al.   BRITISH JOURNAL OF ANAESTHESIA

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

(2008) Miroslav Backonja et al.   LANCET NEUROLOGY

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

(2008) D. M. Simpson et al.   NEUROLOGY

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN

Prevalence of chronic pain with neuropathic characteristics in the general population

(2007) Didier Bouhassira et al.   PAIN